EIP Pharma, Inc.
Boston, MA
- UEI
- ZHHVJ1KU1NA1
- CAGE
- 6WEZ1
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 20 Park Plaza #424, Boston, MA 02116, USA
- Website
- eippharma.com
- Founded
- 2014
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| A phase 2B clinical study of the P38 alpha kinase inhibitor neflamapimod in patients with mild-to-moderate dementia… | National Institute on Aging (NIH) | $100,155,135 |
Quick answers
Is EIP Pharma, Inc. registered in SAM.gov?
Yes. EIP Pharma, Inc.'s SAM.gov registration is active through January 10, 2027.
What is EIP Pharma, Inc.'s most recent federal award?
EIP Pharma, Inc.'s most recent federal grant award is A phase 2B clinical study of the P38 alpha kinase inhibitor neflamapimod in patients with mild-to-moderate dementia… (R01AG080536), from National Institute on Aging (NIH), on February 1, 2023.
On GovTribe
See EIP Pharma, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors